EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device – American College of Cardiology
Dharam J. Kumbhani, MD, SM, FACC
Related Articles
Advances in the treatment of hypertrophic cardiomyopathy
This editorial refers to ‘Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy’, by P. Garcia-Pavia et al., https://doi.org/10.1093/eu
Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
npj Digital Medicine – Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction
Medtronic’s ABRE Study Subanalysis Shows Obesity Paradox After Iliac Vein Stenting – Endovascular Today
November 3, 2024—Medtronic recently announced results from a subset analysis of the ABRE study showing an obesity paradox reflected in outcomes
ACC CardiaCast: Conversations with Critical Care Cardiologists: Echo/POCUS, An Indispensable Tool in the CICU – American College of Cardiology
In this episode, Drs. Rosy Thachil, Shashank Sinha, Smadar Kort and Eugene Yuriditsky discuss the critical role of echocardiography (Echo) and point-of-care ultrasound (POCUS) in…
Home – BSH Annual Meeting 2024 – QEII Centre
QEII Conference Centre, London The British Society for Heart Failure’s Annual Meeting is the heart failure event of the year, bringing together 800 healthcare professionals…
Talking Politics With Patients? In This Election, I Can’t Hold My Tongue
Some doctors strive to remain apolitical with patients. In the most fractious election in US history, I’m moved to speak.
Bleeding Post Mitral TEER Associated With Increased Risk of Death, Readmission – American College of Cardiology
Bleeding following mitral transcatheter edge-to-edge repair (TEER) is associated with increased risk of death or hospital readmission, according to a study published Oct. 28 in…
Philips’ Duo Venous Stent System Studied in VIVID Trial at 24 Months – Endovascular Today
November 3, 2024—The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system (Ro
AIR-STEMI trial Update after FAVOR 3 trial publication – Element Trials
AIR-STEMI trial Update after FAVOR 3 trial publication
